论文部分内容阅读
Objective: Paradigm shifts to neoadjuvant chemotherapy(NACT) for locally advanced and operable breast cancer.Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is less responsive to NACT compared to other intrinsic subtypes.